Surface Oncology's strategy to improve on the first generation of immuno-oncology drugs. Their Phase 2 trials in lung cancer and liver cancer are underway and recruiting.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
